← Leaderboards
Stephen J Ryan
University Of Southern California
$6,625,362
Attributed
$6,625,362
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $409.4K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$6,625,362 · 2
By mechanism
R01$6,625,362 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Mahnaz Shahidi$15,528,269
- David R. Hinton$4,190,679
- Biju Blavady Thomas$2,504,248
Others in their field
Top investigators on “Vascular Endothelial Growth Factors”
- Keri Hammel · The Emmes Company, Llc$41,089,609
- Michael Simons · Yale University$37,207,792
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Shahin Rafii · Weill Medical College Of Cornell Univ$24,406,332
- Rakesh K. Jain · Massachusetts General Hospital$23,479,897
- Aleksander S. Popel · Johns Hopkins University$19,039,579
Research focus
Vascular Endothelial Growth FactorsTransforming Growth FactorsRetinal Pigment EpitheliumDisease /Disorder ModelHuman TissueGrowth FactorTumor Necrosis Factor AlphaTissue Inhibitor Of MetalloproteinasesAnimal TissueCytokineEye Fundus PhotographyEye InjuryFluorescein AngiographyFibroblast Growth FactorAdultCellsApoptosisGrantAngiogenesisChoroidal NeovascularizationCell DeathChoroidCessation Of LifeElectroretinography
Grant awards (19)
An Experimental Approach to Maculopathy$409,375
R01 · FY2012 · EY · contact PI
An Experimental Approach to Maculopathy$387,288
R01 · FY2011 · EY · contact PI
An Experimental Approach to Maculopathy$403,425
R01 · FY2010 · EY · contact PI
An Experimental Approach to Maculopathy$407,500
R01 · FY2009 · EY · contact PI
An Experimental Approach to Maculopathy$399,350
R01 · FY2008 · EY · contact PI
An Experimental Approach to Maculopathy$407,500
R01 · FY2007 · EY · contact PI
RPE CELL IN PROLIFERATIVE VITREORETINOPATHY$317,363
R01 · FY2006 · EY · contact PI
RPE CELL IN PROLIFERATIVE VITREORETINOPATHY$325,000
R01 · FY2005 · EY
EXPERIMENTAL APPROACH TO MACULOPATHY$325,000
R01 · FY2004 · EY
RPE CELL IN PROLIFERATIVE VITREORETINOPATHY$325,000
R01 · FY2004 · EY
EXPERIMENTAL APPROACH TO MACULOPATHY$351,978
R01 · FY2003 · EY
RPE CELL IN PROLIFERATIVE VITREORETINOPATHY$325,000
R01 · FY2003 · EY
RPE CELL IN PROLIFERATIVE VITREORETINOPATHY$365,625
R01 · FY2002 · EY
EXPERIMENTAL APPROACH TO MACULOPATHY$332,903
R01 · FY2002 · EY
EXPERIMENTAL APPROACH TO MACULOPATHY$325,000
R01 · FY2002 · EY
EXPERIMENTAL APPROACH TO MACULOPATHY$325,833
R01 · FY2001 · EY
RPE CELL IN PROLIFERATIVE VITREORETINOPATHY$296,447
R01 · FY2001 · EY
EXPERIMENTAL APPROACH TO MACULOPATHY$303,082
R01 · FY2000 · EY
RPE CELL IN PROLIFERATIVE VITREORETINOPATHY$292,693
R01 · FY2000 · EY